<SEC-DOCUMENT>0001213900-19-012935.txt : 20190717
<SEC-HEADER>0001213900-19-012935.hdr.sgml : 20190717
<ACCEPTANCE-DATETIME>20190717064409
ACCESSION NUMBER:		0001213900-19-012935
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20190717
FILED AS OF DATE:		20190717
DATE AS OF CHANGE:		20190717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immuron Ltd
		CENTRAL INDEX KEY:			0001660046
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38104
		FILM NUMBER:		19958199

	BUSINESS ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
		BUSINESS PHONE:		61 03 9824 5254

	MAIL ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k071719_immuronlimited.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Month of July 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File Number: 001-38104</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B><U>IMMURON
LIMITED</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Level
3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746; Form 40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&ldquo;Yes&rdquo; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMMURON
LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXPLANATORY
NOTE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immuron
Limited (the &ldquo;Company&rdquo;) published three announcements (the &ldquo;Public Notices&rdquo;) to the Australian Securities
Exchange on July 17, 2019 titled:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Proposed Public Offer
    of IMRN ADSs&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Immuron Prices Underwritten Public Offering
    of ADSs&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Immuron to Host Investor Webinar&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Public Notices are attached as an exhibit to this report on Form 6-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report on Form 6-K (including the exhibit hereto) shall not be deemed to be &ldquo;filed&rdquo; for purposes of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) and shall not be incorporated by reference into any filing under
the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B><BR>
    <B>Number</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="f6k071719ex99-1_immuron.htm">Proposed Public Offer of IMRN ADSs</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="f6k071719ex99-2_immuron.htm">Immuron Prices Underwritten Public Offering of ADSs&rdquo;</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="f6k071719ex99-3_immuron.htm">Immuron to Host Investor Webinar</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center">1<P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMMURON LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&nbsp;&nbsp;July 17,
    2019</FONT></TD>
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 37%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Phillip Hains</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phillip Hains</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f6k071719ex99-1_immuron.htm
<DESCRIPTION>PROPOSED PUBLIC OFFER OF IMRN ADSS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Immuron
Announces Proposed Public Offering of ADSs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Melbourne, Australia, July 17, 2019: Immuron
Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin
therapeutics for the treatment of gut mediated diseases, today announced that it intends to offer and sell American Depositary
Shares, or ADSs in an underwritten public offering. Each ADS represents forty (40) ordinary shares of Immuron. Immuron expects
to grant the underwriters a 45-day option to purchase additional ADSs offered in the public offering. The offering is subject to
market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size
or terms of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Immuron intends to use the net proceeds
from the proposed offering for expenses associated with the clinical development of its clinical candidates and working capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ThinkEquity, a division of Fordham Financial
Management, Inc., is acting as representative of the underwriters in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shelf registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419005438/s117275_f3.htm">Form F-3</A> (File No. 333-230762) relating to the ADSs to be issued in the proposed offering was filed with the Securities and Exchange
Commission (SEC) and was declared effective on April 17, 2019. This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A preliminary prospectus supplement and
accompanying prospectus describing the terms of the proposed offering will be filed with the SEC. The securities may be offered
only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Copies
of the preliminary prospectus supplement and the accompanying prospectus relating to the securities being offered may also be
obtained from ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd&nbsp;Floor, New York, New York
10004, by telephone at (877) 436-3673, by email at&nbsp;prospectus@think-equity.com. Electronic copies of the preliminary prospectus
supplement and accompanying prospectus will also be available on the SEC&rsquo;s website at&nbsp;http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1.5pt solid; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-top: Black 1.5pt solid; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-top: Black 1.5pt solid; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; padding-right: 0; padding-left: 0">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Level 3, 62 Lygon Street,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Carlton South, Victoria</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AUSTRALIA 3053</P></TD>
    <TD STYLE="width: 33%; padding-right: 0; padding-left: 0">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">www.immuron.com</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABN: 80 063 114 045</P></TD>
    <TD STYLE="width: 36%; padding-right: 0; padding-left: 0">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Phone: + 61 (0)3 9824 5254</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Facsimile: + 61 (0)3 9822 7735</P>

</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ABOUT IMMURON:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Immuron Limited (ASX: IMC, NASDAQ: IMRN),
is an Australian biopharmaceutical company focused on developing and commercializing orally delivered polyclonal antibodies for
the treatment of inflammatory mediated and infectious diseases. Immuron&rsquo;s technology platform utilizes highly specific vaccines
for the generation of hyperimmune antibody-rich bovine colostrum, providing a means of antimicrobial therapy without the drawbacks
of antibiotics to treat gut-mediated diseases. The Company currently markets Travelan<SUP>&reg;</SUP>, which is a listed medicine
on the Australian Register for Therapeutic Goods, in Australia to reduce the risk of travelers&rsquo; diarrhea. In Canada, Travelan<SUP>&reg;
</SUP>is a licenced natural health product, and is indicated to reduce the risk of travelers&rsquo; diarrhea. In the U.S. Travelan<SUP>&reg;
</SUP>is sold as a dietary supplement for digestive tract protection. Immuron&rsquo;s lead clinical drug candidate, IMM-124E,
is presently in Phase II trials in severe alcoholic hepatitis (ASH), and pediatric non-alcoholic fatty liver disease (NAFLD),
respectively. The Company recently announced plans to pursue clinical development of IMM-124E through a formal FDA registration
pathway as a drug to specifically prevent travelers&rsquo; diarrhea. Immuron&rsquo;s second clinical-stage asset, IMM-529, targets
<I>Clostridium difficile </I>infections (CDI), and is presently in a clinical trial in CDI patients. The Company plans to file
an IND with FDA to focus its further development specifically to treat patients with recurrent CDI.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>COMPANY CONTACT:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Gary S. Jacob, Ph.D.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ph: +61 (0)3 9824 5254</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">info@immuron.com</P></TD>
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AUS INVESTOR RELATIONS:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Peter Taylor</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NWR Communications</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ph: +61 (0)4 1203 6231</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">peter@nwrcommunications.com.au</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>USA INVESTOR RELATIONS:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dave Gentry - CEO </B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RedChip Companies, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">US Ph: +1 (407) 491 4498</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">dave@redchip.com</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information visit: http://www.immuron.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FORWARD-LOOKING STATEMENTS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release may contain &ldquo;forward-looking
statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, each as amended. Such statements include, but are not limited to, any statements relating to the closing of the offering,
the intended use of net proceeds from the offering, our growth strategy and product development programs and any other statements
that are not historical facts. Forward-looking statements are based on management&rsquo;s current expectations and are subject
to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock value. Factors
that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy;
our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results
of research and development activities; risks relating to the timing of starting and completing clinical trials; uncertainties
relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain
key personnel; the early stage of products under development; our need for substantial additional funds; government regulation;
patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim
any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to
reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based,
except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 2 of 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>f6k071719ex99-2_immuron.htm
<DESCRIPTION>IMMURON PRICES UNDERWRITTEN PUBLIC OFFERING OF ADSS"
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immuron
Prices Underwritten Public Offering of ADSs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melbourne,
Australia, July 17, 2019: Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing
and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced the pricing of
an underwritten public offering of 339,130 American Depositary Shares, or ADSs. Each ADS represents forty (40) ordinary shares
of the Company. Each ADS is being offered at a public offering price of USD$4.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has also granted to the underwriter a 45-day option to acquire an additional 50,869 ADSs to cover overallotments in connection
with the offering, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering is expected to close on July 19, 2019, subject to customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity,
a division of Fordham Financial Management, Inc., is acting as representative of the underwriters in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs described above are being offered by Immuron pursuant to a shelf registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419005438/s117275_f3.htm">Form F-3</A> (File No. 333-230762)
previously filed with and subsequently declared effective by the Securities and Exchange Commission (SEC) on April 17, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated gross proceeds to the Company are expected to be approximately USD$1,356,520 prior to deducting underwriting discounts,
commissions and other estimated offering expenses. Immuron intends to use the net proceeds from the proposed offering for expenses
associated with the clinical development of its clinical candidates and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein,
nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A preliminary prospectus
supplement and accompanying base prospectus relating to this offering&nbsp;have been filed with the SEC and are available at the
SEC&rsquo;s website at http://www.sec.gov. Before investing, you should read the preliminary prospectus supplement and the accompanying
prospectus for information about Immuron and this offering. A final prospectus supplement related to the offering will also be
filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of the final prospectus supplement and accompanying prospectus relating to the offering, when available,&nbsp;may be obtained
from ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd&nbsp;Floor, New York, New York 10004,
by telephone at (877) 436-3673, by email at prospectus@think-equity.com. Electronic copies of the final prospectus supplement
and accompanying prospectus will also be available on the SEC&rsquo;s website at&nbsp;http://www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT
IMMURON:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immuron
Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally
delivered polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases. Immuron&rsquo;s technology
platform utilizes highly specific vaccines for the generation of hyperimmune antibody-rich bovine colostrum, providing a means
of antimicrobial therapy without the drawbacks of antibiotics to treat gut-mediated diseases. The Company currently markets Travelan<SUP>&reg;</SUP>,
which is a listed medicine on the Australian Register for Therapeutic Goods, in Australia to reduce the risk of travelers&rsquo;
diarrhea. In Canada, Travelan<SUP>&reg;</SUP> is a licenced natural health product, and is indicated to reduce the risk of travelers&rsquo;
diarrhea. In the U.S. Travelan<SUP>&reg;</SUP> is sold as a dietary supplement for digestive tract protection. Immuron&rsquo;s
lead clinical drug candidate, IMM-124E, is presently in Phase II trials in severe alcoholic hepatitis (ASH), and pediatric non-alcoholic
fatty liver disease (NAFLD), respectively. The Company recently announced plans to pursue clinical development of IMM-124E through
a formal FDA registration pathway as a drug to specifically prevent travelers&rsquo; diarrhea. Immuron&rsquo;s second clinical-stage
asset, IMM-529, targets <I>Clostridium difficile </I>infections (CDI), and is presently in a clinical trial in CDI patients. The
Company plans to file an IND with FDA to focus its further development specifically to treat patients with recurrent CDI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
        CONTACT:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gary
        S. Jacob, Ph.D.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)3 9824 5254</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">info@immuron.com&#9;</FONT></P></TD>
    <TD STYLE="width: 34%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUS
        INVESTOR RELATIONS:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peter
        Taylor</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NWR
        Communications</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)4 1203 6231</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">peter@nwrcommunications.com.au</FONT></P></TD>
    <TD STYLE="width: 33%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USA
        INVESTOR RELATIONS:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dave
        Gentry - CEO </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip
        Companies, Inc.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
        Ph: +1 (407) 491 4498</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dave@redchip.com</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information visit: http://www.immuron.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements include, but are not limited to,
any statements relating to our growth strategy and product development programs, our expected uses of the net proceeds of this
offering and any other statements that are not historical facts. Forward-looking statements are based on management&rsquo;s current
expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial
condition and stock value. Factors that could cause actual results to differ materially from those currently anticipated include:
risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and
relationships; risks relating to the results of research and development activities; risks relating to the timing of starting
and completing clinical trials; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers;
our ability to attract, integrate and retain key personnel; the early stage of products under development; our need for substantial
additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described
in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on
which any such statement is based, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2 of 2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>f6k071719ex99-3_immuron.htm
<DESCRIPTION>IMMURON TO HOST INVESTOR WEBINAR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<IMG SRC="ex99-3_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immuron
to Host Investor Webinar on July 18 to Provide Update on Recent Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MELBOURNE,
Australia &ndash; July 17, 2019 - Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company, announced
today that it will participate in an investor webinar and Q&amp;A session on Thursday, July 18, 2019, at 10:30 a.m. EST (US time),
hosted by RedChip Companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
webinar will feature a presentation by CEO Gary S. Jacob, Ph.D who will discuss recent achievements and upcoming milestones related
to the company&rsquo;s development pipeline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
register for the free webinar, please visit: https://www.redchip.com/corporate/webinar_register/43</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; padding-right: 0; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
        CONTACT:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gary
        S. Jacob, Ph.D.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)3 9824 5254</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">info@immuron.com&#9;</FONT></P></TD>
    <TD STYLE="width: 33%; padding-right: 0; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUS
        INVESTOR RELATIONS:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peter
        Taylor</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NWR
        Communications</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)4 1203 6231</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">peter@nwrcommunications.com.au</FONT></P></TD>
    <TD STYLE="width: 34%; padding-right: 0; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USA
        INVESTOR RELATIONS:</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dave
        Gentry - CEO </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip
        Companies, Inc.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
        Ph: +1 (407) 491 4498</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dave@redchip.com</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT
IMMURON:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immuron
Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally
delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases. Immuron has a novel
and safe technology platform with one commercial asset generating revenue. In Australia, Travelan<SUP>&reg;</SUP> is a listed
medicine on the Australian Register of Therapeutic Goods (AUST L 106709) and is indicated to reduce the risk of Travellers&rsquo;
Diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. In Canada, Travelan<SUP>&reg;</SUP> is a
licenced natural health product (NPN 80046016) and is indicated to reduce the risk of Travellers&rsquo; Diarrhea. In the U.S.,
Travelan<SUP>&reg; </SUP>is sold as a dietary supplement for digestive tract protection in accordance with section 403 (r)(6)
of the Federal Drug Administration (FDA). Immuron&rsquo;s lead clinical candidate, IMM-124E, is presently in Phase II trials in
Severe Alcoholic Hepatitis (SAH) and Pediatric Nonalcoholic Fatty Liver Disease (NAFLD). The company now has plans to develop
a U.S. registration dossier for IMM-124E for Travellers&rsquo; Diarrhea. Immuron&rsquo;s second clinical-stage asset, IMM-529,
targets <I>Clostridium difficile </I>Infections (CDI), and is presently in a clinical trial in CDI patients. These products together
with the Company&rsquo;s other preclinical immunotherapy pipeline products currently under development targeting immune-related
and infectious diseases are anticipated to meet pressing needs in the global immunotherapy market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information visit: http://www.immuron.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="ex99-3_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-3_003.jpg" ALT=""></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements include, but are not limited to,
any statements relating to our growth strategy and product development programs and any other statements that are not historical
facts. Forward-looking statements are based on management&rsquo;s current expectations and are subject to risks and uncertainties
that could negatively affect our business, operating results, financial condition and stock value. Factors that could cause actual
results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain,
perform under and maintain financing and strategic agreements and relationships; risks relating to the results of research and
development activities; risks relating to the timing of starting and completing clinical trials; uncertainties relating to preclinical
and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the
early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual
property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking
to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations
or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-3_002.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !2 10# 2(  A$! Q$!_\0
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M4G*4%&*<I2BDY+T?]E#_ (.?_P#@GG^T+XCTWP7\4HO'W[*GB76+J*RTV_\
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MG>>%?AMKVO20HWAGQII=IJ5SI'A;4[F&Y\'>.-(O?##BSAU2.0\G$_ F0XC
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MZ)I]MX:_;BTG2='7[)9Z!^UW::=I:1?(+6UT_P",JVUI%%M/R+# B1Q@8"J
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M_3UH]?S4?\$!O^3[[_\ [(AXY_\ 3KX:K^EK_@JJC2?\$\/VL%0$M_PJV[;
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M]8M?RT_\'(W_ !_?LC?[OQ?_ /1?@:OZEJ_"/_@M%^PS^TE^V5<_L]R_L_\
MA/0?$\?P_'Q#'BC^VO&.B>%#9GQ"GA<:4;8:Q+']N$QTR\$OV?)@\M#)@2+7
MQ/@EFF6Y+XF\-YEF^/PF69?AWFGUC&XZO'#86C[7)\?1I>TK34HP]I5J0IPN
MK2G.,;J]SZSQ9R['YKP!GV RS!XG'XVO_9WL<)A*4J^(J^SS/!U9^SI1:E+D
MIPE.5G[L(RE9I6.E_P"" ?\ R87/_P!EU^*'_HGPS7[;U^87_!)#]F;XP_LG
M?LG2?"KXXZ%I?AWQNWQ3\<^*?[/TCQ!IOB6T.C:Y'HBZ=<?VEI4DMKYLILK@
M26Q82P[!O #KG]/:\/Q-QN#S+Q"XSQ^7XJAC<#C.(<?B,)C,+4C6P^)H5'AN
M2M0JP]VI3GRRY9QT?*^Q[' &$Q6!X)X5P>-P];"8O"Y)@J.)PV(@Z5>A6@JZ
MG2JTY>]"<>:/-%ZJZ[G^<Z?^3\W_ .SR#_ZND5_=E^W=_P F7_M2_P#9"?B7
M_P"HKJ5?S$2?\$>_V]G_ &L)/BNOPT\'GP5_PTD_Q$%\WQ2\()=-X3'Q/;Q+
M]O\ [-%S]J^T'1\7 LMOV@R?N-OFD"OZJ?VJ_ 7B?XI_LU?'?X;^"[.WU#Q=
MXY^%7C;PMX;L;N^@TVUN]:UK0;VPTZWN-0NBMO9PRW,T:27,Y$4*DNY"@U^U
M>-7$W#N<YWX25\ISS*\RI95@<NAFE3!8REB(9?4IYIPI4J0QDZ:Y:+A3PN(J
M24FVH4*KE9TVC\F\*.'\\RK)_$FEF64YC@:N8XC&SR^GBL)5H3QL)Y=Q'3A+
M#1FVZRE.O0A'EM>5:FK)SB?QB_\ !$#_ )2+_!?_ +$OXJ_^H)>U_=Q7\J/_
M  2]_P""6O[:/[,7[97PT^+_ ,8O 'A70O 7AWPOX^TW5]3TKXB>&/$5W;WF
MN>%KC2],C33=-N'O)A/>S)&[QHRPH&DD(7-?U75\O](S/,EX@X]PN.R'-L!G
M."APWEN'>+RW$T\5AU7IXK-)5*+J4[)5(1JTY2@TI1C.#:5SZ+P-R?-<DX-Q
M&#SC+L9EF+>>XZLL-CL//#5G1GALNA"JJ=1MNG-TYJ,EHW&2T:9_)M_P<>_\
ME4_9<_[$+XB_^I!X>K]0/^"$W_*/#P'_ -E#^+7_ *FNH5X+_P %G?V!_P!I
M[]L?Q]\"=>^ 'A#P]XFTSP-X2\9:5XDFUKQIH/A66UOM8U?1[NPBMX=8EC>\
M26"SG=Y(,K$RA'Y85]R_\$J/V=?BQ^RU^Q[X8^$/QIT33/#_ ([TKQGX_P!8
MO-/TG7;#Q':#3]>\0SZCID_]J:8[V<DLMM*I>*-V:$!4DQ)N ]3B3B'(<1]'
M7@WA_#YSEM;/<'GE&OB\GIXNG/,L/16-XEFZM;"*/M*=-1Q.'DY2E91K4G9J
M:MYV19)G%#QQXISJME>/I91BLIK4L-F<\-4C@:]66%R"*ITL2WR2GS8>M%12
MNY4JB5G!W_1ZO\Z_X%_\I _A7_V>1HG_ *N)J_T4*_C>^%G_  1__;V\,_M:
M>!/BUJ_PV\(6_@G0_P!HS2_B+J.I+\4/",U_%X5M?B/_ ,)#-?KID-R;N2[_
M +)'VC[!&IN#*?("[^*CP$X@R+(\!XF4\ZSC+<JGF7"ZPN7QS#%T\++&XCZM
MQ%#V&%51/VU52Q%!<D;.]:FK^^B_&;)LXS;&< SRG*L?F<<!Q!+$XV6"P\ZZ
MPM!5\DE[6OR?PX.-"LU.6G[N?\K/ZP?V@OA38_'/X'?%GX/:BRI;?$CP!XG\
M)"9^$MKO6-*N;;3[MN#Q9W[6UT>#_J:_S^OV=OB_\2OV"_VL?#GCR]T"[C\:
M_!3QEK7A+XA^"[MOL=QJVE*T_A[QKX;:1QMAFOM/::XTJY=3$MRFFW>'A(-?
MZ,M?B7_P4O\ ^"0?AG]L/5;CXT_!S6=)^''[0"V,5MKBZI!*/!7Q/M["$16*
M>)/L44MWH_B2UMT6RM/$MG!<BXMD@M=5M)DACNH?/\$/$+(>&IY_PCQE%?ZI
M<88=8?%XB4*LZ6!Q;P]3!2GB514JT,'C,'6]A7KTH3GA*V'PN*Y'"%1P[?%S
M@G.,^ADW$O"]WQ)PQ6=;#T8RA"KB\,JU/%QCAW4:I3Q6&Q5%5:5&I*$<32JU
M\.I1G.'/^@'P*_;E_98_:(\$6'CCX=_&;P,;:XLXKG5- \1>(M(\-^*_#-PT
M2O<:=XB\/ZM>VU]I]U9.6AGDV2V,C(9+6[N(&25OQJ_X+&?\%1?A/)\(/%?[
M*G[/?C/2OB!XT^(D2Z%\2_&'A2^AU+POX+\'^>DNK:%;:]:/)8ZKXF\1I"FF
MO#ID]S;Z9I,]]+=S"ZE@@7\-O''_  2B_P""@7@G79]'O_V7/&?B:6)_)36?
M LVA^+M$NU)P)(-3T[4 XA;.<7<-M(HSOB4AA7U'^S1_P0N_:^^+NMZ7-\7]
M*T[]G7X=">-]6O\ 7+W3-;\>362M&9[;0?"&DW-Q!:W\T99(;K7KZSM+<YD,
M-TR>0WZ;E/AKX*\'9Q1XRQOB7@,WRG+,1#-,KR=XS*,34E7HSCB<%&O'+L3B
M,RS-T*L*<J6&AEN!GB*M*B\9[.,*L*GP&9\>>*_$^5U>%L)P%C<NS+'T99?F
M.9QPN98=>QJQ=#%.B\=1HX#+E6IRJ0JXB>88J.'IU*OU;VCG3E#V/_@WS_9Z
MU;Q?^T1XZ_:+OK">/PA\(?"%]X-T+47BVVM]X\\;QP17EE:NP"S/H_A:*ZEO
M#%N-M)JUBDFTSJ*_1+_@XA_Y-(^%G_9>M"_]1+Q;7[&_L\?L]_##]EWX2^%O
M@Q\(M"70_!_A>W<(97$^J:WJMT1)JOB+7[_8DFI:[K%R#<W][(JY/EV\$<%I
M;V]O%^?O_!8O]E#XX?M>_L]^ ?A_\!_#ND^)?%.A_%K2O%.I6>L>)-*\,6T&
MB6OAWQ%837*WVKR1P22+=7]K&((RTI60N!M1J_.:7B-@N+?'K(.,<=7IY1D.
M$SC!X;!U<QJPH0P639?A,SI4*V-J.4Z=&IB*E>IBL0E*4*=7%PI)R=-RG]S4
MX&Q?#?@WG7"^$I3S+.<3E>*KXJ&!IRK3Q>:8W$Y?4K4L+32A.K"C"C##T=(N
M<,/.I:,9Q4?B+_@V_P#^24_M2_\ 94/ O_J&7%?TF5^*W_!&#]C/]H+]C?P'
M\>- ^/\ X7T7PSJ7CCQQX3USPU'HOBS1O%45YI^E^&[C3;Z2:;1Y)$LY(KMD
M18I]KRHP=,JI-?M37Q/C)F67YOXF<69EE6-PN8Y?B\;A9X7&X*M'$87$0CE>
M64Y3HUHJ,9J-2G4IR:2M.G./2[^N\+L#C<MX!X;P.8X3$8'&X?"8B&(PF*I2
MHXBC-YACYJ-6E/WH2<)PFDV_=G%IM.Y^2\'[,FO?L5?M2_%_X[?!'PGJ/B[]
MEK]L;48=7_:L^#'AFT%[KOPM^,JV;Z4/VC?AQH*XDUKPQXSTJ1M+^-?@O24D
MUF*\@TOQUX?LM32VU?25^(/V*/BUH/@JU_:>_P""0GQR\6)X*O-7C^+7A/\
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MAZ=#(^'<-2HSJ1]IA:-2<JF'HU:L*$E3PWMJU:EBZ\_R4_X-O/\ D8OVL?\
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M+P[XM\(:-X3_ &9-4\97WB_P_K46LMXB\11^)(K!+1/#;V-G-IJ/;FT<W/\
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M!1XK6+P]2@\=Q=G^/P?/R?[1@\52RV.'Q$.6I/\ =UG1JJ'/R3]R7-3CI?\
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9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !2 10# 2(  A$! Q$!_\0
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M4G*4%&*<I2BDY+T?]E#_ (.?_P#@GG^T+XCTWP7\4HO'W[*GB76+J*RTV_\
MBU::;J'P[N+RXE\FVM9_B#X8N;VPT=YY&B1;CQ!IVCZ;&SM]HOX40NW]&>F:
MGINM:=8:QHVH6.K:3JEG;ZAIFJ:9=V]_IVHV%Y$EQ:7UA>VLDMM=V=U!(DUO
M<V\LD,\3I)$[(P8_Q_\ QS_X)9_\&_/[67B2X^#G[-/Q8T3]G3X]:O)+I'@S
M6?A?KWBS4_ .K^))3Y=KHU[HOC3[=X*\4QW,Z_9UL-'US2KZ[#O'IM\\S1(U
M7_@CY\;/VLO^"7W[7?B;_@CK^VG'=>+="\2^'M9\=_L:>*(=4=_#_B,:1'>Z
MG>>%?AMKVO20HWAGQII=IJ5SI'A;4[F&Y\'>.-(O?##BSAU2.0\G$_ F0XC
MU\=PO@^)N'\UP>"_M;%<(<88.O@\=BLEBXJMG&1XK%4<.\=A\)S*IC*2=5T<
M/SUG.FJ4SR,MSW(,^P^)Q>09SEF<X?!UJF'Q<\IS#!YI##XBE#GJ4*D\OQ&*
M4:\8>_[%VJ2A[T%4C9O^QBBO.?AE\5_ _P 7=#O-<\$ZL;U=(U>]\.>)='O;
M>;3?$7A+Q1I;*FJ>&/%6AW:QW^B:[ISNGVBRNXE\R&2&[M)+FQN+:YFB^,OQ
M5\+? WX4_$'XO^-;C[-X6^'/A36/%>L,KJDL\&E6DD\=C;%_E-YJ5R(-/LE;
MA[NZ@0_>K\@6!QCQL,N^JU_K]3$4L)#!NE)8B>)KU*-*C1C2:4G.K4Q%"--*
MZFJU*4)2A4A4ET1QV"G@WF,,50G@(T*N)>,A5A+#K#T8U9UJKJQ;BHTHT*_M
M+VE3E1JPG"%2G.E#E_CY^TK\#?V8?![>.?CI\1_#WP^T%W>"P.K7+2:KK=XB
M%_L.@:'9I<ZOK5X1@-#IUE<>3O5[AH8SOK\C]=_X.%/V,=.UF2PT;P7\<_$F
ME12!/[>M?".CZ=;S*#AI8+#5/$5MJ+1=6C,MO#(Z8+11D[1_,-\8?BW^T)_P
M42_:7BU^_L-:\;_$KXCZ\?#WPT^'6E.\MCX3T.>>672?"GA^VD=;33--TBQ4
MW7B#6IO(%S)%?ZSJURRDLO[)^ _^#<OXE:KX,AU'XC?M(>&_"/CJZLUG_P"$
M8\,^"+CQ1X?TFZ>(.MC?>(+W6](NK]XI#Y-U<:=I\4&4+6S3IM9OZLCX0>%'
M .69:_%GBC%PX@S.C&M_9F68FO1I81-Q4X4J& P&/S#$TL/-RH5<QQ7U3!U:
M].M'!TJT*?,_YTEXG>(_&688Y>&_#V&EDN7U'3^OX^A2J5,392<'.MC<7@\%
M1J5Z:C7I8'#^WQ-.C4HRQ%2$IN*_=O\ 9=_X*2_LB?M=WZ>'?A-\3(8?'+6Q
MNC\._&EA/X1\:/$@S*;#3=2(MM;\CDS_ -@WVIF)%,L@2(;Z^[J_SM?VL?V.
M_P!H/]@7XLZ#H/Q =M.O&NCXA^%OQ<\#7M];:/KKZ/<1N-3\.:KMM]2T/Q#H
M\QMI;[1[L1:A9"6&<?:K&>*>3^OW_@DK^V]J?[:'[.!N/'EU;W'QF^$NIVW@
MCXDW$*) /$(>S%UX:\:BV0!()/$FFQRC4HHE$*:WI^IF%8X)(8D^&\4?"+*N
M&\BP/'/ V<SX@X,S"K2I3J5*E/$5\OGB93AAJGUNC1P\<3A*M:G4PE1U\-A<
M;@<9".&Q=)NHIQ^N\//$W,<]S?%\(<7Y7#).*L%"K.%.$9T:6-AAXQG7A+#5
M*E5X?%4Z,X8F"HU\1A,9A92KX:JE3E!_J;1117X$?LX5_G2_'O\ Y/U^*W_9
MW&M_^K5%?Z+5?YTOQ[_Y/U^*W_9W&M_^K5%?U3]%O_D8^(/_ &2E#_U,S$_G
M;Z0O^X<%_P#90U__ %$P9_?'^U#-+;_LS?M"SPR-%-%\#_BK)%(A*NCIX%UU
ME=6'(92 01T-?P]_\$@-"L_$'_!0G]E^VO;);Z+3]5\1^((HFC\U8;W0O 7B
M#4+*^*]%:RN8DN4D(_=2(D@PR@U_<!^U/_R;#^T3_P!D,^*__J":[7\5'_!%
M+_E(K^SS_P!@7XE?^JQ\0UGX(U)4O"CQNJ0;C..3NS3:>O#>:P>JL_AJ36^S
M:ZN]>+4(U/$CPFA)7C+,XIIZK3/LOEL]'K"+U71=D?WI5_*3_P ''WARPM_'
M/[+'BZ.*--3U/PS\2O#-U,JJ)9K#2=1\-:M9QRN%W.EO<:M=M$"Q"&XEV@;V
M)_JVK^6G_@Y&_P"/[]D;_=^+_P#Z+\#5\!]'Z<H>+/"ZBVN>.<TYV;7-"61Y
M@W%V:NFX0;3NGRK316^R\:X1GX;<0<R3Y)Y54C=)VG'-\&E)73LTIR5U9^\]
M>_US_P &]WA73-*_8N\8>*;>&-=5\7?'3QBFJW 0"6:+PYH_AO3=-AD?&YDM
MXI)S&I)"F:0CEVS^[4D<<T;Q2HLD4J-')&ZADDC=2KHZL"K*RDJRD$$$@C!K
M\2_^" ?_ "87/_V77XH?^B?#-?MO7SWB[.=3Q/X[E.3E)<28^";;;4:<<%"G
M%.][0A&,8KHDDK'N^&D(P\/^#XQBHIY#@YM)))RJ/%3FW9:N4I-M]6[NY_G(
MZ)I]MX:_;BTG2='7[)9Z!^UW::=I:1?(+6UT_P",JVUI%%M/R+# B1Q@8"J
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M_3UH]?S4?\$!O^3[[_\ [(AXY_\ 3KX:K^EK_@JJC2?\$\/VL%0$M_PJV[;
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M]8M?RT_\'(W_ !_?LC?[OQ?_ /1?@:OZEJ_"/_@M%^PS^TE^V5<_L]R_L_\
MA/0?$\?P_'Q#'BC^VO&.B>%#9GQ"GA<:4;8:Q+']N$QTR\$OV?)@\M#)@2+7
MQ/@EFF6Y+XF\-YEF^/PF69?AWFGUC&XZO'#86C[7)\?1I>TK34HP]I5J0IPN
MK2G.,;J]SZSQ9R['YKP!GV RS!XG'XVO_9WL<)A*4J^(J^SS/!U9^SI1:E+D
MIPE.5G[L(RE9I6.E_P"" ?\ R87/_P!EU^*'_HGPS7[;U^87_!)#]F;XP_LG
M?LG2?"KXXZ%I?AWQNWQ3\<^*?[/TCQ!IOB6T.C:Y'HBZ=<?VEI4DMKYLILK@
M26Q82P[!O #KG]/:\/Q-QN#S+Q"XSQ^7XJAC<#C.(<?B,)C,+4C6P^)H5'AN
M2M0JP]VI3GRRY9QT?*^Q[' &$Q6!X)X5P>-P];"8O"Y)@J.)PV(@Z5>A6@JZ
MG2JTY>]"<>:/-%ZJZ[G^<Z?^3\W_ .SR#_ZND5_=E^W=_P F7_M2_P#9"?B7
M_P"HKJ5?S$2?\$>_V]G_ &L)/BNOPT\'GP5_PTD_Q$%\WQ2\()=-X3'Q/;Q+
M]O\ [-%S]J^T'1\7 LMOV@R?N-OFD"OZJ?VJ_ 7B?XI_LU?'?X;^"[.WU#Q=
MXY^%7C;PMX;L;N^@TVUN]:UK0;VPTZWN-0NBMO9PRW,T:27,Y$4*DNY"@U^U
M>-7$W#N<YWX25\ISS*\RI95@<NAFE3!8REB(9?4IYIPI4J0QDZ:Y:+A3PN(J
M24FVH4*KE9TVC\F\*.'\\RK)_$FEF64YC@:N8XC&SR^GBL)5H3QL)Y=Q'3A+
M#1FVZRE.O0A'EM>5:FK)SB?QB_\ !$#_ )2+_!?_ +$OXJ_^H)>U_=Q7\J/_
M  2]_P""6O[:/[,7[97PT^+_ ,8O 'A70O 7AWPOX^TW5]3TKXB>&/$5W;WF
MN>%KC2],C33=-N'O)A/>S)&[QHRPH&DD(7-?U75\O](S/,EX@X]PN.R'-L!G
M."APWEN'>+RW$T\5AU7IXK-)5*+J4[)5(1JTY2@TI1C.#:5SZ+P-R?-<DX-Q
M&#SC+L9EF+>>XZLL-CL//#5G1GALNA"JJ=1MNG-TYJ,EHW&2T:9_)M_P<>_\
ME4_9<_[$+XB_^I!X>K]0/^"$W_*/#P'_ -E#^+7_ *FNH5X+_P %G?V!_P!I
M[]L?Q]\"=>^ 'A#P]XFTSP-X2\9:5XDFUKQIH/A66UOM8U?1[NPBMX=8EC>\
M26"SG=Y(,K$RA'Y85]R_\$J/V=?BQ^RU^Q[X8^$/QIT33/#_ ([TKQGX_P!8
MO-/TG7;#Q':#3]>\0SZCID_]J:8[V<DLMM*I>*-V:$!4DQ)N ]3B3B'(<1]'
M7@WA_#YSEM;/<'GE&OB\GIXNG/,L/16-XEFZM;"*/M*=-1Q.'DY2E91K4G9J
M:MYV19)G%#QQXISJME>/I91BLIK4L-F<\-4C@:]66%R"*ITL2WR2GS8>M%12
MNY4JB5G!W_1ZO\Z_X%_\I _A7_V>1HG_ *N)J_T4*_C>^%G_  1__;V\,_M:
M>!/BUJ_PV\(6_@G0_P!HS2_B+J.I+\4/",U_%X5M?B/_ ,)#-?KID-R;N2[_
M +)'VC[!&IN#*?("[^*CP$X@R+(\!XF4\ZSC+<JGF7"ZPN7QS#%T\++&XCZM
MQ%#V&%51/VU52Q%!<D;.]:FK^^B_&;)LXS;&< SRG*L?F<<!Q!+$XV6"P\ZZ
MPM!5\DE[6OR?PX.-"LU.6G[N?\K/ZP?V@OA38_'/X'?%GX/:BRI;?$CP!XG\
M)"9^$MKO6-*N;;3[MN#Q9W[6UT>#_J:_S^OV=OB_\2OV"_VL?#GCR]T"[C\:
M_!3QEK7A+XA^"[MOL=QJVE*T_A[QKX;:1QMAFOM/::XTJY=3$MRFFW>'A(-?
MZ,M?B7_P4O\ ^"0?AG]L/5;CXT_!S6=)^''[0"V,5MKBZI!*/!7Q/M["$16*
M>)/L44MWH_B2UMT6RM/$MG!<BXMD@M=5M)DACNH?/\$/$+(>&IY_PCQE%?ZI
M<88=8?%XB4*LZ6!Q;P]3!2GB514JT,'C,'6]A7KTH3GA*V'PN*Y'"%1P[?%S
M@G.,^ADW$O"]WQ)PQ6=;#T8RA"KB\,JU/%QCAW4:I3Q6&Q5%5:5&I*$<32JU
M\.I1G.'/^@'P*_;E_98_:(\$6'CCX=_&;P,;:XLXKG5- \1>(M(\-^*_#-PT
M2O<:=XB\/ZM>VU]I]U9.6AGDV2V,C(9+6[N(&25OQJ_X+&?\%1?A/)\(/%?[
M*G[/?C/2OB!XT^(D2Z%\2_&'A2^AU+POX+\'^>DNK:%;:]:/)8ZKXF\1I"FF
MO#ID]S;Z9I,]]+=S"ZE@@7\-O''_  2B_P""@7@G79]'O_V7/&?B:6)_)36?
M LVA^+M$NU)P)(-3T[4 XA;.<7<-M(HSOB4AA7U'^S1_P0N_:^^+NMZ7-\7]
M*T[]G7X=">-]6O\ 7+W3-;\>362M&9[;0?"&DW-Q!:W\T99(;K7KZSM+<YD,
M-TR>0WZ;E/AKX*\'9Q1XRQOB7@,WRG+,1#-,KR=XS*,34E7HSCB<%&O'+L3B
M,RS-T*L*<J6&AEN!GB*M*B\9[.,*L*GP&9\>>*_$^5U>%L)P%C<NS+'T99?F
M.9QPN98=>QJQ=#%.B\=1HX#+E6IRJ0JXB>88J.'IU*OU;VCG3E#V/_@WS_9Z
MU;Q?^T1XZ_:+OK">/PA\(?"%]X-T+47BVVM]X\\;QP17EE:NP"S/H_A:*ZEO
M#%N-M)JUBDFTSJ*_1+_@XA_Y-(^%G_9>M"_]1+Q;7[&_L\?L]_##]EWX2^%O
M@Q\(M"70_!_A>W<(97$^J:WJMT1)JOB+7[_8DFI:[K%R#<W][(JY/EV\$<%I
M;V]O%^?O_!8O]E#XX?M>_L]^ ?A_\!_#ND^)?%.A_%K2O%.I6>L>)-*\,6T&
MB6OAWQ%837*WVKR1P22+=7]K&((RTI60N!M1J_.:7B-@N+?'K(.,<=7IY1D.
M$SC!X;!U<QJPH0P639?A,SI4*V-J.4Z=&IB*E>IBL0E*4*=7%PI)R=-RG]S4
MX&Q?#?@WG7"^$I3S+.<3E>*KXJ&!IRK3Q>:8W$Y?4K4L+32A.K"C"C##T=(N
M<,/.I:,9Q4?B+_@V_P#^24_M2_\ 94/ O_J&7%?TF5^*W_!&#]C/]H+]C?P'
M\>- ^/\ X7T7PSJ7CCQQX3USPU'HOBS1O%45YI^E^&[C3;Z2:;1Y)$LY(KMD
M18I]KRHP=,JI-?M37Q/C)F67YOXF<69EE6-PN8Y?B\;A9X7&X*M'$87$0CE>
M64Y3HUHJ,9J-2G4IR:2M.G./2[^N\+L#C<MX!X;P.8X3$8'&X?"8B&(PF*I2
MHXBC-YACYJ-6E/WH2<)PFDV_=G%IM.Y^2\'[,FO?L5?M2_%_X[?!'PGJ/B[]
MEK]L;48=7_:L^#'AFT%[KOPM^,JV;Z4/VC?AQH*XDUKPQXSTJ1M+^-?@O24D
MUF*\@TOQUX?LM32VU?25^(/V*/BUH/@JU_:>_P""0GQR\6)X*O-7C^+7A/\
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MAZ=#(^'<-2HSJ1]IA:-2<JF'HU:L*$E3PWMJU:EBZ\_R4_X-O/\ D8OVL?\
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M+P[XM\(:-X3_ &9-4\97WB_P_K46LMXB\11^)(K!+1/#;V-G-IJ/;FT<W/\
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M!1XK6+P]2@\=Q=G^/P?/R?[1@\52RV.'Q$.6I/\ =UG1JJ'/R3]R7-3CI?\
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9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !* 0P# 2(  A$! Q$!_\0
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MQZEK/BTZK!>SX^]/9:1H\;G)6TB!"K]'?LK?\'!GQ"T_Q-IWAK]K?P3H6O\
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MO>#/"_@CP#IUY<6^F>)/&FCGQ1XW\0V\+*L>J7-C)=CPYX>@N0KNFD)8ZW/
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MW@]+77/"OAQKF-9)8]!M="\9ZE NR8>(!(&@B\TT+]IW_@Z:\"Q)\3+WP?\
MM6^(=%@C?4KW1?$W[-?A#7;2XLTC:25;OP=;?#B/Q!86XBW.XT^STV>)0'22
M,J"/ZROV#_\ @GE^R9_P2=_9ZNKG2HO#%KXITGPF-9^.W[2'BVUL[3Q%XFFT
M^U^V:U.^JW(FN/#?@>QN!*OA[P;IMQ]EMX%MGO/[9\1W-[JU_P#E_P#M#_\
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M8[^S<WA"FJ"KO]]&EBG0BW"A6=7"XK#8JE2;HK$4/:4.6EB(PC_%3_P< _\
M)]FC_P#9#? /_I^\:5_5W^Q+_P F<_LK_P#9O7P>_P#4!T&OY1?^#@#G]NW1
MO^R'> /_ $_^,Z_J]_8J4)^Q[^RRHZ#]GOX/8S_V(&@5]CXE?\F?\(5_TYJ/
M_P Q5='Q_AO_ ,G>\7/^OU/_ -6E _B?_:L7?_P5/^+"<'?^USJB 'IE_B05
M&?;)YX/':O[_ "OX"?VI #_P57^*((R#^V!? @]"/^%F#@U_?M5^.W_(H\*U
M_P!4G%_^6/#")\#%_P *_BD_^JKDONQO$K_4_+/_ (+1 '_@G)\>L@'%S\,3
MR,X(^*O@O!]B.QK\<O\ @W#3/Q?_ &D),'Y?AMX53/8;_%#M@^Y\O(^AK]D_
M^"S?_*.3]H#_ 'OAK_ZM7P57XX_\&X7_ "5G]I3_ +)WX/\ _4ENJOA)_P#'
M/GB!_P!CB:^^?#!GQ8O^.@. ?^Q1#\(<3']:E?Q;_P#!P>@7]M_PE(.K_L_>
M!,\8(V>,OB2!SU/7/M7]I%?Q=?\ !PC_ ,GM^#_^S?O W_J9_$FO!^CX[>(U
M'_L0Y[_Z9P+_ $/>^D K^'=;_L>Y'_Z?QJ_4_J$_X)],6_8:_9)).<?L]_"I
M<^R>#]*0?D% K^,?]O=_M/\ P4[^-V\@@_'\0'&#\L6J6-N!SD9"1A2"",C&
M,<5_9E_P3S_Y,7_9+_[(%\,__48T^OXR_P!O!"G_  4[^-JG//[0KOSZ2:U9
MR#\,,,>V*^U\%4EXB>)G=83/K>7_ !E.:[?<CXOQF;?A[X:=I8O(K_\ B+Y5
M_P $_O[K\[_^"L5M'=_\$\_VFHI4#JGA/P]< ,,XDM/'WA*YC<<'!1XE8'MC
M.17Z(5^??_!5/_E'S^T]_P!B/IW_ *F'AJOP#@MM<8\)M;KB;(+?^'?+_P#-
MG[YQDD^$.*T]GPUGW_JHQ_\ DC\$/^#<N//[07QYEQRGP<MH\^GF^-O#;8Q[
M^2/ICWK^O.OY%/\ @W)_Y+O^T#[?"32\>V?&.D9_/ SZX'I7]==?H'CV[^)>
M:>669"OE_9LG^I\#X#JWAMEGGF6>O[\RBOT/XV?^#B*/;^UW\+Y,#]Y^S_X=
M&>YV>/?B-U'MN.*_HI_X):2&7_@G[^R^Q[> +B/\(?$^OQ#N>R?_ %ATK^=G
M_@XD8']KCX6*.J_ #0,_\"\??$7'\J_HA_X)7?\ */K]F'_L1;__ -2WQ'7U
M/'FO@1X8-[K%TE\OJ>?_ *)'RW K_P"-Z>)JZ/"5?PQF0?JV?R0_MFL+?_@J
MW\3Y9?E2/]INPF8D@?NQXHT]\Y/ !7G)[<U_?!7\%'_!6+PUK_PF_P""D?QI
MU>XMS#_:GBOPQ\2/#=S*K>3?6&MZ%H>LI<Q8Y>*VU?\ M'392O'VG3[B,89"
M!_;U\!?C1X-_:&^#_P /_C)X#U&VU'PYX\\.:?K4(MYEEDTR_EA5-8T"_523
M!JOA_54O-'U2V?YX+VRF0[E"NT^-5&IB>$?"C-J$)5< N&Z>"EB8)RI0Q%3+
M,BKTJ<Y)-1E4CA,5R*37-+#UH*\Z<HJ_!>M3PW%OBKE-><:6.?$=3&1P\VHU
M9X>GF>>4:E2$79RC3GB\+SN*?+'$49.T:D9/UVOX<?\ @N>0?^"AWC( @E?!
MOPP##T/_  B6E-@^^&!^A%?W%R21PQR2RR)%%$C22RR,J1QQHI9Y)'8A41%!
M9F8A54$D@ FO\_\ _P""D_QATO\ :J_;\^*/B7X7E?$NB:AXH\-?#OP+/IN9
MT\3GPKI.C>#8;[39%S]JM?$.M:==7NCS1C%Q87UDZ*2^*YOHX8:M+C/-,?[.
M2P>!X=Q4,5B6K4:,\5C,!["$ZCM%2G'"8FHHN5_9T*M1I0@Y+H^D9B:,>#<L
MP#J1>,QO$.%GA<.G>M6AA<'CO;SA35Y.,)8O#4W)1:]I7I4TW.:B_P"Z+]GE
M=GP ^!J8QL^#WPS7'IM\%Z(,?AC%?PK_ +'GARR\5?\ !3GX/:3J%NMU:K^T
M]I^JR02#='(V@>-'UV,.IX9%DTY&93P0I!!'!_O9^'OAR3P=X!\#^$97627P
MKX/\,^')9$.Y'DT/1;+3'=6_B5FM2RGN"#7\*/[!1Q_P54^$>>G_  O[7Q^<
M^O ?J1CWQ7?X-5[Y=XR8FC)^]D&,KTIIM.U2'&%6G)-6:;C5C)/1JZV9P^,5
M"V8>#N&K15XY]@Z%6$DFKTZG"-.I%K5-<U&46M4[=5O_ 'O5_(E^RQ\*X9/^
M#I_]LW5_'%GOU?PK\']<^)WP_DO(P[.?$W@3X'>$['4]/DDSE+;PAXTUW1RT
M>#&6GA!40LM?UVU^(G[>GP&\1_ +]MC]G;_@K-\,/#FJ>)='^%WAW4_@G^V?
MX1\,Z;>ZMXDO_P!G+Q''J$,7Q=T31-,2;4->NO@W?:F?$GBS2M-M+_6=3\,:
M)I$MI;BR\.7SC\@X-Q\<//B'+/:*C6XAX9S+)\'4E)03QTIX7&87#N<G%0^O
MRP=; 0<I1BZV)P].4DJR9_2M"5O:PO9U*4X)_P![245_V]RN/JUW.F_X*<?#
M_P"*O[8GQ(^"W[ _PO\ $T/@OP_XIT+6OCO\>?%ES%/<V^E?#[PKK5AX:\(6
M\FGV[P/K7V_Q7=:E+9Z$UW:K>:]IN@W\EQ:6>DWVH67G/A#_ (-\OV,M%L;9
M/%/C+XW>,=20(UW<MXC\*Z#I\\@"^8L&GV/@Z>[MK=V!V1OJ]S/&C;6NI7'F
M'ZK\3?%#PKX)_P""A_P&\=7&MZ5?_#C]K7]ENX^%?PY\:Z=>0W_A[5/&O@CQ
MX_Q*\+V]GKEL\NER67C3PW\0+B/098[D_P!N:D=(MM-^U-/\O\U7_!S5^W?^
MW'\%_P!I_P !? +X6?$WXD_ [X%WGP?T3QEINI?#36-:\$WWQ*\1ZMKFOV'B
M6?5?&>@3V&JZA;>'#I>F:5'X7@U*.STQF75[ZSEFUNPF3]"X9Q?&]:/"O!W"
MF=OA;+\7D.(SVKBZ,%1J8_'/&9A3SFMB*T,-5QF*Q6$Q&&PV6PP5.=%86EAE
M[6,$Y3/S#!\#\+<6<0<2YEG^6X7.LVP^;SRM4\SE6K4<LRW!8'+:N68?#8-8
MBC2IPQ5#&8C,)5G3G+$U:]6:DHT917]<'ACPW^R__P $^OV?)-/BU7PE\#O@
M;\/;74M:U77O&'B06MHMQ.KWFIZIJVN:[=R7NLZYJ31!(+=)+F^NC'::3H]E
MY<5C8)^?_P#P1$\3Z5\6_@/^UE^T)X;TJYTSX9?M/?\ !0;]J?XU?"[3[^S-
MHUQX U_4O#'ARUU"XL)8U%M=ZMJWAG6[G5K/:T<&I->6^YS&S'^#3]C3]C?]
MN?\ X*T?&;0O!FE^(?BAXY\*:9J]DOQ$^-OQ0\0>*_%?@KX7:'(5>_OM0UO7
M]0NA?>('T]ICH7A#3;S^V]?N'CC1+33!J&K6'^E)9V_P%_X)G?L6:-H=I(OA
M_P"#O[-_PSL]"T2WN[B!=8\3ZA8P,MK;"0K''?\ C/XA^*KF6YN9$CCCN_$.
MN75Y(EO:F9X?+XPX<AP]&KD:SO$<5<9\5YIE]3&QI4YNI1A1Q-6O056,Z^*Q
M57,<SS'&4N1XB=.JL/1E-4:5%^T?Z+7HY9P]EDJ:EA,#E^7X3FE&$*>%P67Y
M?@J,ZC2A'EITJ5*G"3Y;)**:492J?O?EO_@E/XRFTO\ X; _9;%TESH?[+/[
M3?CSPO\ #^)#(4T?X;^*/$_BF;P_X?B,DDC/#INK^'?$L\3;@(TU!;9$CAMX
MD'\P/[3EK%JG_!6#XD6%W&L]O??MBW%A<0R#='-;3_$]+62%P<@I)$Q1E((*
MDC&.*_>__@@O8>*_&7A7]K;]I;Q7;R0W?QW^-EM,)6618+S4-%3Q#XIUZZL/
M- >2Q.I?$?[)'+]P364]N,/;2*OX0?M$@?\ #W7QL,#!_;3@R,<'/Q5MLY'O
MDY]<\U^Q<"X:G@?$WQ4P].<)UL/PE@EC:E)IPEF\<OP$LWJ1<;+FJ9K'%UIM
M6;JU:DW[TY'\B<;XBICO#3PMQ%2$X4:_%>,>"IU4U*.4RS#'QRFG*,M>6&52
MPE&"=TJ5*G!7C")_>]1117\>']?'\+W_  7 MH8?^"B_Q*DCBC1KOP[\*YYB
MBA3+*/A]X8@WRX'SOY<,:;CSM10>E?VG? R[N=0^"7P=O[QF>[O?A9\/KNZ9
MSEVN;GPEI$T[.>[-*[%CW)-?Q<_\%QO^4BGQ!_[%CX6_^H)X=K^TGX(8_P"%
M+?"#:H4?\*O\ 84=%'_")Z3A1[ <#VK^B/%C7PS\'&U>7]DR7-ULLER_2^]K
MI/>WNKLC^>O"G3Q+\84G:/\ :R]U:*_]LY@[VVO9M;=6?R$?\%_-&U>;]N/0
M+R+3+][2Y^"'@1+:Y6UF,$[0^(O&4<HAEV>7*8Y66.0(S;)#M;!P*_JR_8RL
M]0T[]D7]F"PU:RNM-U.S^ 'PBMKZPOK>6UO;.YA\!Z$DMM=6TR)-;W$+*4FA
ME1)8W#)(BN"!]&7%G:7>W[5:VUSLSL^T013;,E6.WS%;;ED1CC&2BD\J,6:_
M.N)>/7Q#P?PAPF\KCA%PK"</KZQDJSQW-AIX:+6'>'IK#6C-SDO;5KR246HW
M9^B<-\!KA_B_B[BM9I+%OBJ<)_47A(T5@>7$PQ,D\0J]1XB\H<D7[*C:+;DG
M*R/X'OVE?#^O:C_P5:^)4-EH^IWLUS^V%?&WBMK*XGDG67XG!X/*2.-FD\R-
MD:(*"75E9<A@3_?#59;*S2=KE;2U6Y9BS7"V\2SLQ&TLTH02%B."2V2.#Q5F
MGQWQ\^-<+PMA?[+66KAG*(Y6IK&/%/&-4<MHNNXO#T%05LN4E33JM>U:<WR+
MF7 O :X+Q7%&*_M1YB^),WEFCA]46%6#3K9E55!2^L5W7?\ PH.+J-4E^Z34
M/??+^7__  64TS5]5_X)U?'RVT;3KW5+E&^'-W/;V%O+=31:?9_$_P '7.H7
MCQ0J[BULK6.2ZNYBOEV]M%+/,R11NZ_CW_P;DZ+K=O\ %#]I+5)]*U"'25\!
M>#[&349;6:.S74)_$%U<VMF9V01FYGM8+NXCB#%S##))C;R?ZPG1)$>.1%DC
MD5D='4,CHP*LCJP*LK*2&4@@@D$$&HK>UM;1#':VT%LC-N9+>&.%&8*J!BL:
MJ"P1$3)&=JJN<* *RGQ EE?A]Q!P(LJC76>XWZW_ &H\9*F\,I/+)2I_5%0D
MJTE_9J4)_6*:7MI<T7R1YIS7@&.:>(&0<=/-947D>"^J_P!F+"1J+$N,<RC"
MHL6Z\713_M&3G#V%1OV,>62YY<L]?QE?\'!&D:O=_MJ^#KJWTK49K1O@%X)A
MBNX[.X:UFEC\9?$9IHH9Q'Y4DD(DC\Y$=FB\R/>%WKG^S6H)[6VN=OVFW@N-
MF[9Y\,<NW=C=M\Q6V[MHW8QG ST%<'A]QE_J)Q'3S_\ LY9IR8''8)X5XIX.
MZQM.A#VBK*AB+.G[&_(Z;4^9KFBTK]WB!P=_KUP[4R#^T'EG/CL#C5BEA5C+
M/!5*T_9NBZ^'NJGMK<ZJ)PY4^65VE\E_L!:??:5^Q'^REI^IV=UI]_:_ 7X9
M1W-G>P2VUU;R'PMIS[)[>94EB?:RMLD16 (R!7\<_P#P4*\*>)-)_P""GOQ=
MDU'0-7L8M3^-6E:SISW.GW<2:AIFHS:1>6>H63/$!=6EU#,DD$\!DCDW;48L
M"H_O3JK/8V5S(DMS9VMQ+$,123V\4LD8SNPCR(S(-W/RD<\]:]G@KQ)GPAQ'
MQ'Q \HCF"XBH9C2J818V6&^JO'9GB<RC*%=X:O[9498F5%QG2@ZD8J:<)-Q/
M'XS\-X<6\.\.9 LWG@'P[6RZK3Q;P4<2L4L#EN&RV49T5B*/LG5CAE63A5FJ
M<I.#4XI2+5?G[_P50M+R]_X)^?M-V]C:7-[<-X)TR06]I#)/-Y-OXQ\-7%U-
MY<2L_DVMK%-=7,F-D-M#+-(5CC=A^@5-=$D5D=5='5D='4,KHP(964@AE8$A
ME((()!&*^!R;,7E&<93FRHK$/*\SP&8J@YNFJ_U'&8?%>Q=11FZ?M?8>SYU"
M7)S<W++EY7]YG.7K-\HS7*G6>'69Y;C\N==051T?KV$Q&%]LJ;E!5/9>WY^1
MSBI\O+S1YN9?R1_\&Z.C:W;_ !R_: U";2K^'2X?A1I=C<7\EK,EI#J-UXNT
M>YL;*2=D")<W5K::A<00E@\D-I<2*I6)B/ZWJ@@M;6U#BUMK>V$C!I!!#'"'
M95"!G$:KN8* H+9(4!1P *GKZ#CWBU\;\38OB)X!9;]9PV PZPBQ#Q7(L%AO
MJ_.Z[HT.:51MS:5**@N6*YG>3\#@/A-<$\-87AY8]YE]6Q./Q+Q;PZPO.\;B
M?K#@J"K5^54TE!-U9.3YI6BFDOX[/^#B'1M6/[5OPEU1=.O&TZ]^!.C65I>B
MWD-K<WEEXZ\?27=I!.%\N6YMH[NTDN($9I88[JVDD54N(B_]#W_!+[3K_2OV
M!/V8[+4[*ZT^\3P!+.UK>02VUPL-[XDUV]M)3%,J.(KJSN(+JWDV[)K>:*:,
MM'(C'[JNK"QOO+^VV5I>>26:'[5;0W'E,P 9H_-1_++!0&*X) &>@JV
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MY\#_  [\*_#/PIISL.(I!#J%MIVCVA('G3:1HFK2C[R6DQ&*_*/7O%O[<?\
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MGQ=?(^&,7A,LGG-&3C7H/&8O&YI&L\'7C!5(R@Z].<+U,/&I.-.O1^D?V?\
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MH **** "BBB@ HHHH **** /Q3_X)&?\E._X*7_]GJ?$'_U*O&]?M97XI_\
M!(T?\7-_X*7'M_PVI\01^7BGQOG^8K]K*^[\2O\ DL\S_P"P3A[_ -93A8^&
M\-_^2.RW_L+XA_\ 6JXG/P _X)@_\F,_M^?]EC_:3_\ 53^&Q_+CZ5\T?\$<
M[Z\_9M^('P&M+Z]N%^&W[??PE\>W6E-=W$KVUE\;_@-\3/'FCR:="73[-:Q7
MG@F NBAEFOM2\0Z7:*9#;1(?I?\ X)@?\F,_M^?]EC_:3_\ 53^'*\7\!_#?
MQ!KW_!%?]G'XV_#^/;\5/V3/'7BW]H?P1<H9DD:U\$_''Q[/XPT^X>W!FDTI
M_#C76N:A8A62_D\.V=O(I0FOV7'U*-3&^(V38N<*>#XGX[R#ARM4JM*G0Q.8
M<$2GDV,E*7P+!Y_A<GJRG=<M&OB6WRW1^-Y?3K4\#X<YQA83J8SAG@7/N(J-
M.G=U*^'R_C:,,XPD8QUF\9D.*S>E&%GS5J&&LN;E/TM_X*H^.-=?X&^$/V:O
M EX]M\2?VQOB5X8^ ^A20+YDNF^%=9U&SE^(6OW,09=VC6>AM!HFMR?,MM9>
M)3<2+Y4;LOR)_P $>_"6F^ OV<_V]_ VCS37.D>#?VE/C/X5TJXN6WW$^F^'
M_ 'A_2K&6=\#?-):VD32M@;G+' !P/0_V=/B'H/[?_\ P4#;]H[PVYU/X*_L
MG_!#PSH7P\DDC\VTD^,GQOT(:QXNO+>:0!6U+PUH%SJ_@[Q!;K"K6NJ:#HUT
MC*&A>7 _X)6?\DA_X*/?]G:_M ?^HAH]?*5,//)/#_-^%JM-T<=@ZW ^>Y[2
MG%1JTLXSWB?%K#X.LK<T:F6Y#@<OH3IR:]G6S"LG%2;9]73Q$,[X^RCBBE45
M; XNEQMD61582<J57*,CX:PKQ&,HM/EE3S+/<;CZT*D5^\HY?1:DXI);7_!'
M+X6_#+XJ?\$Z/AEIGQ/^'7@3XCZ;IOQ$^*-]IVG^/?"/A_QA8Z?>OXGO;=[R
MRM/$.GZC!:W3P,T+7$$<<S1,8RY0E:\X^,_[/7P!T[_@L)^R+\/]/^!OP>L?
M >O_ +/WC[5==\$V?PS\&6OA'6M4M=/^,;6NIZMX;@T6/1M2U"U;3[%K>\O+
M*:XA:RM#'(IMH=GT%_P0U_Y1[> /^QZ^)_\ ZEMY7._'3_E-E^Q?_P!FW_$7
M_P!-OQNJZN.QU/Q*\4:%/'8VG0IY5XGUJ="GC<93HTZT<MIU(UJ=&GBX4:=6
M-3]Y&K3I0JQG[\:L9^^9T<#@:GAMX7UZF!P52O4S/PRHU*]3!X.I6J499C.G
M*C4K5,).M4I2I_NY4IU9TI0]R5*4/</=_P!N3X)_!GX5?L-_M;7OPP^$GPQ^
M&]YJWP8\0VNJW?@+P%X5\'W.I6L CFAMM0N/#VE:=+>6\,I,L4-R\D<<A+HH
M;FOG']B.W_X)IG]D3]G)OB9;_L-M\0&^$7@QO&#>.;?X#-XQ;Q =)A_M(^)6
MU]#K9UG[2'^W'5#]M,V[S_FS7VY_P4A&?V$OVIP>A^$'B8'_ +]15\K_ +"_
M["/['7CS]CG]FGQGXR_9P^%?B+Q5XF^#G@C6?$&NZIX:@N=2U?5+[1K>:[U&
M^N'8O/=7<K&::1OO,QP%7"CP\IS'#+P\K8C.LVXIH.IQVX1Q.28NG4QU:<.$
M:=J>*K9EFF'E/#PIJ].*Q%5QJ))4X0U/<S7+\2_$&CA\ERKA>LJ? O/+#9UA
M:E/ TH3XMJ7J86CEN5XB,,1.II4D\/24J;;=2<]']<Z)H_[*47PB^-^L?LQZ
M5^SY#!+\/_%.F^*M4^!-A\.8HI9(O#.L7.GV&OWW@"%4D>)99[BSM=1E)022
MRPH [L?S]_X(\_LY?L]?$/\ 8+^%_BGQ_P# CX->./$]_P"(_B=#?>)/&'PP
M\$^)=?O8K/XA>(K2SCN]8UK0[W4;A+2TBBM;9);AE@MXHX8@D:*H_2G_ (4%
M\&/@)\%_C-I/P9^&OA/X;:;K_@?Q;?ZU9^%-,BTR#4KRT\*ZM;VUQ=I&3YLD
M$,DD<1)PBR/@9=B?CS_@B2"/^"=OPD)'7Q-\5R/<?\+*\3#(_$$?4&N6.82A
MP-Q=BLJS+/'3GQGPA3HXS'XRI1S:I161\1)PQ5; 9A--*<9*-.&+J4O9PHW@
MI)QAURP"GQMPEALTRW)%4AP=Q=4K8/ 82%;*:=9YWP\U/"T<=E\))N$HN52>
M$IU?:3JVDXM2G\S?MT?!OP9_P3M^)?P _;7_ &7M%MOA3I5[\6?#_P *OCS\
M.?"ADTWP%XW\$>)8-2U-IG\+P2+I>F7$%GH^L6:K86T=A#JUUH.NVUE;ZKI4
MEQ?_ +^U^&'_  5;\=:#^T1XS_9I_8)^%^HV/C'XE^./CIX7\9_$2PT&Z@U,
M_#_P+X7L=7M=0N_%#VLDB:5.;+6=0\1M9SD7T.D>&;JXFMXDO],-[^Y]</%U
M3%XGA;@+%YS*M5SVOAN(4\1C'.68XGAZCFF$IY!5Q=2M?$UZ49O-Z.75\5*I
M4G@::C2JU,+3HM=O"5/"8?BCCO"9/&C2R.AB>'VL/@U".78;B"MEF+J9]2PE
M.C;#4*DH+*:V84,+&G3ACJCE5I4\34K191117YV?H04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!^77B+_ ()!_L@>)/&7CCQW<1_%O3->
M^(GB[7_&_B@Z#\4M<T>QO/$'B75K[6M3N([.TC6.*(WNHW1MXB7^SPN(D;:.
M?0?@K_P32_9P^ GQ,\,_%CP)>_%N3Q3X3?4Y-+C\1?%'Q!KNB.VK:+J6@W0U
M#1[DI:ZA&+'5;IH(KD/%#>+;7BIY]M Z?H)17U-;C?C#$86>!K\2YO6P=7#?
M4ZF&J8I3I3PGL8X;ZO)2PKDZ7U>$**C[72G",5))*WR]'@GA##XN&.H<-Y11
MQE+$_7*>)IX5PJPQ7MIXCZQ%QQ2BJOMYSK.7L]:DY2<6Y._R_P#!S]D'X,?
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HMP6$R_!T>;V6%P6'I8;#T^9\TW&E1A"'-.3<IS:E.<FY3J3D^8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-3_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !4 S$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU[/K04RO<:C87$]G=R%?WMO-)&1@U^5_[./Q _X*Q?\ !2/POH?P<^%/QO\
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M"N%,NG3MR5J>29=6Q*<=I+%8ZAF6+YEOS*NIWUYD]3\=SSQ2\4>*%46>\?\
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M;S3/[*]3_P"#@G]E*VD9-,^&GQDOE&=LMW'X"T^,D=B(/&6IR*3[1MQR?2N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-3_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  R +<# 2(  A$! Q$!_\0
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MFAZ_I-_]K59+2*0>'O"ZQ;P1JNCMBZ@^N_\ @GKX;MOV#_\ @BY^SWK?[/\
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M'Q+I,K&&WT'Q;H_@?PSXHTBZ2_U?7M!\/?D=_P %?O@U_P %:_VW?V@OAO\
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=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
